Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India
暂无分享,去创建一个
H. Nair | Rutuja Patil | S. Juvekar | Sudipto Roy | D. Agarwal | A. Bavdekar | H. Kaur | G. Dayma | Sanjay Mehandale
[1] N. Sharma,et al. The seroprevalence of severe acute respiratory syndrome coronavirus 2 in Delhi, India: a repeated population-based seroepidemiological study. , 2021, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[2] Jitendra Narayan,et al. Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India , 2021, Travel Medicine and Infectious Disease.
[3] L. D. de Witte,et al. High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond? , 2021, Epidemiology and Infection.
[4] Sarang V Dhatrak,et al. SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey , 2021, The Lancet Global Health.
[5] Bhavin Solanki,et al. Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study , 2021, BMJ Open.
[6] Md. Zakiul Hassan,et al. Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis , 2020, Vaccine.
[7] M. Arunachalam,et al. National Guidelines for Ethics Committees Reviewing Biomedical & Health Research during COVID-19 Pandemic: An analysis. , 2020, Indian journal of medical ethics.
[8] G. Kang,et al. Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India , 2020, The Lancet Global Health.
[9] M. Venkataswamy,et al. Descriptive epidemiology of SARS-CoV-2 infection in Karnataka state, South India: Transmission dynamics of symptomatic vs. asymptomatic infections , 2020, EClinicalMedicine.
[10] D. Buonsenso,et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposition to adults with COVID-19: preliminary findings , 2020, medRxiv.
[11] G. Corbi,et al. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making , 2020, Aging Clinical and Experimental Research.
[12] A. Flahault,et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study , 2020, The Lancet.
[13] Eric J Topol,et al. Prevalence of Asymptomatic SARS-CoV-2 Infection , 2020, Annals of Internal Medicine.
[14] R. Pandey,et al. National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India: Protocol for community-based surveillance , 2020, The Indian journal of medical research.
[15] P. Santhosh,et al. First confirmed case of COVID-19 infection in India: A case report , 2020, The Indian journal of medical research.
[16] D. Larremore,et al. Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys , 2020, medRxiv.
[17] M. Day. Covid-19: four fifths of cases are asymptomatic, China figures indicate , 2020, BMJ.
[18] Malik Peiris,et al. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[19] W. Ko,et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths , 2020, Journal of Microbiology, Immunology and Infection.
[20] M. Lipsitch,et al. Defining the Epidemiology of Covid-19 - Studies Needed. , 2020, The New England journal of medicine.
[21] P. K. Anand,et al. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 , 2020, The Indian journal of medical research.
[22] K. Dierickx,et al. Benefit sharing in the revised Indian National Ethical Guidelines for Biomedical and Health Research Involving Human Participants. , 2018, Indian journal of medical ethics.